In other countries
The same active substances on other registers, the same brand first.
- EnzeevuUnited States · 2MG/0.05ML · Injection · Sandoz Inc.Same brand
- EnzeevuUnited States · 2MG · injectable · Sandoz INCSame brand
- EydenzeltBrazil · Celltrion Healthcare Distribuicao de Produtos Farmaceuticos Dos Brasil LtdaSame substance
- EyliaBrazil · Bayer S.A.Same substance
- PavbluBrazil · Amgen Biotecnologia do Brasil Ltda.Same substance
- Afqlir 40 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 40 mg/ml · solución inyectable en jeringa precargada · Sandoz GmbhSame substance
- Ahzantive 40 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 6,60 mg · solución inyectable en jeringa precargada · Formycon AgSame substance
- Baiama 40 MG/ML Solucion Inyectable en Jeringa PrecargadaSpain · 6,6 mg · solución inyectable en jeringa precargada · Formycon AgSame substance
- AfivegEuropean Union · STADA Arzneimittel AGSame substance
- AfqlirEuropean Union · Sandoz GmbHSame substance
- AhzantiveEuropean Union · Formycon AGSame substance
- AfqlirCroatiaSame substance
- EydenzeltCroatiaSame substance
- EyleaCroatiaSame substance
- AfqlirItaly · Soluzione iniettabile · Sandoz GMBHSame substance
- AhzantiveItaly · Soluzione iniettabile · Formycon AGSame substance
- BaiamaItaly · Soluzione iniettabile · Formycon AGSame substance
- Afiveg 40 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Stada Arzneimittel AGSame substance
- Afiveg 40 mg/ml oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Stada Arzneimittel AGSame substance
- Afqlir 40 mg/ml oplossing voor injectie in een injectieflaconNetherlands · Oplossing voor injectie · Sandoz GmbHSame substance
- EyleaNew Zealand · Inj 40 mg per ml, 0.1 ml vialSame substance
- EYLEA 40mg/mlRomania · 40mg/ml · sol. inj. · Bayer Pharma AGSame substance
- EYLEA 40mg/mlRomania · 40mg/ml · sol inj. · Bayer AGSame substance
- ZALTRAP 25 mg/mlRomania · 25mg/ ml · conc. pt. sol. perf. · Sanofi - Aventis GroupeSame substance
- Eylea®Serbia · 114.3mg/mL · rastvor za injekciju · Bayer D.O.O. BeogradSame substance
- Eylea®Serbia · 40mg/mL · rastvor za injekciju · Bayer D.O.O. BeogradSame substance
- Eylea®Serbia · 40mg/mL · rastvor za injekciju · Bayer D.O.O. BeogradSame substance
- EYLEA 40 mg/ml solution for injectionSaudi Arabia · Bayer AGSame substance
- Eylea 40 mg/ml Solution for injection in pre-filled syringeSaudi Arabia · Bayer AGSame substance
- EYLEA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 40 mg/mlSingapore · 2.0mg/50mcl · injection, solution · Bayer (South East Asia) Pte LTDSame substance
- Eylea Solution for Injection in Vial 2MGSingapore · 2.0mg/50mcl · injection, solution · Bayer (South East Asia) Pte LTDSame substance
- Eylea Solution for Injection in Vial 8MGSingapore · 114.3mg/ml · injection, solution · Bayer (South East Asia) Pte LTDSame substance
- EYLEA 114.3 mg/ml solution for injectionTaiwan · 注射液劑 · 台灣拜耳股份有限公司Same substance
- Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection vialTaiwan · 注射劑 · 台灣拜耳股份有限公司Same substance
- Eylea aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringeTaiwan · 注射劑 · 台灣拜耳股份有限公司Same substance
- AhzantiveUnited States · 2MG/0.05ML · Injection · Formycon AGSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Aflibercept
- Strength
- 2 MG / 0.05 ML
- Dosage form
- Solution
- Route
- Intravitreal
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 9 Feb 2026
- Registration
- DIN 02562510
- Marketing authorisation holder
- Sandoz Canada Incorporated
- ATC code
- S01LA05
- Group
- Sensory organs
- Supply
- PRESCRIPTION, SCHEDULE D